SB 1057 Summary

• Allows licensed prescribing health professionals to prescribe, administer, or dispense long-term antimicrobial therapy (more than 4 weeks) for patients clinically diagnosed with Lyme or tick-borne diseases based on medical history, physical examination, and/or CLIA-certified laboratory testing.

• Prohibits health profession regulatory boards from initiating disciplinary action against prescribing health professionals for prescribing long-term antimicrobial therapy for Lyme or tick-borne diseases if the diagnosis is documented and treatment is based on recognized evidence-based assessments, guideline recommendations, or standards of care.

• Defines "Lyme or tick-borne disease" broadly to include acute and late-stage infections, complications from initial infections, and other variances including borrelia and viral, parasitic, bacterial, and other infectious agents.

• Allows boards to take disciplinary action against prescribing health professionals for reasons other than the treatment provisions in this section, pursuant to existing regulatory authority.

• Official name: "Ryan Montgomery Lyme Disease Treatment Act."